Investigated metabolic parameters could not differentiate non-surviving patients from surviving patients (data not shown).
Further, NRBC peak values tended to occur earlier in surviving patients, whereas non-surviving patients tended to have a NRBC peak a few days later (survivors: 5 (3, 9) days; non-survivors: 7 (3, 17) days; p = 0.08).
However, the r value in non-surviving patients with LC was higher than in surviving patients with LC, indicating that the LMR changes in non-surviving patients with LC were more pronounced, which coincided with table 3 results.
The mean APPS was 5 in surviving patients and 6 in non-surviving patients (Additional file 1: Figure E1; P < 0.001).
We found higher serum SP levels (P =0.002) in non-surviving patients (n =27) than in surviving patients (n =73).
Non-surviving patients received cyclophosphamide more frequently than surviving patients.
When considering the first consecutive 30 days on the ICU, NRBC values of non-surviving patients were consistently higher than in surviving patients (Fig. 2a).
Surviving patients had higher day 1vitamin D levels as compared to non-surviving patients.
The surviving patients began improving soon after receiving the antitoxin that had arrived that day.
To date there has been no indication of spontaneous recovery of cellular immunocompetence in our surviving patients.
Surrounded in darkness and dust, surviving patients, staff and volunteers began to dig out those caught in the rubble.
